Article
Personalising pancreas cancer treatment: When tissue is the issue.
World journal of gastroenterology - 28 Jun 2014
Sjoquist Katrin M, Chin Venessa T, Chantrill Lorraine A, O'Connor Chelsie, Hemmings Chris, Chang David K, Chou Angela, Pajic Marina, Johns Amber L, Nagrial Adnan M, Biankin Andrew V, Yip Desmond
Abstract excerpt
The treatment of advanced pancreatic cancer has not moved much beyond single agent gemcitabine until recently when protocols such as FOLFIRINOX (fluorouracil, leucovorin, irinotecan and oxaliplatin) and nab-paclitaxel-gemcitabine have demonstrated some improved outcomes. Advances in technology es...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.